Immuneering Corp - Class A Common Stock, par value $0.001 per share (IMRX)

62 filings reported holding IMRX - Immuneering Corp - Class A Common Stock, par value $0.001 per share as of Q3 2024.
Immuneering Corp - Class A Common Stock, par value $0.001 per share (IMRX) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4.36M shares of 64M outstanding shares and own 6.81% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.07M shares), PRICE T ROWE ASSOCIATES INC /MD/ (810K shares), MORGAN STANLEY (449K shares), BlackRock, Inc. (318K shares), MILLENNIUM MANAGEMENT LLC (246K shares), GEODE CAPITAL MANAGEMENT, LLC (210K shares), SOUTHPORT MANAGEMENT, L.L.C. (205K shares), Prosight Management, LP (190K shares), TD Asset Management Inc (151K shares), and MANUFACTURERS LIFE INSURANCE COMPANY, THE (82.6K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.